# Open-label Study of TAK-875

> **NCT01433419** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 333 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** TAK-875
- **DRUG:** TAK-875

## Key facts

- **NCT ID:** NCT01433419
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 333 (ACTUAL)
- **Last updated:** 2013-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01433419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01433419, "Open-label Study of TAK-875". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01433419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*